RecruitingNot ApplicableNCT07341997

Environmental Factors Associated With Peripheral Neuropathies in French Guiana


Sponsor

Admin CIC

Enrollment

78 participants

Start Date

Dec 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Peripheral neuropathies (PN) affect 1% of the global population, particularly the elderly. About 20-30% of cases remain unexplained. In French Guiana, we hypothesize that factors like neurotoxic traditional plant remedies, arboviral disease outbreaks, and mercury exposure from illegal gold mining may contribute to PN. The study aims to assess the association between PN and exposure to arboviral infections, heavy metals, and plant consumption in French Guiana.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • For the Case group: patients diagnosed with diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy
  • For the Control group: patients hospitalized or consulting at the hospitals in Cayenne and Saint-Laurent du Maroni, without peripheral neuropathy.

Exclusion Criteria1

  • For the Case and Control groups: patients under the age of 18, those who object to participation and those who are unable to complete the questionnaire.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCase Group

Patients diagnosed with diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy.


Locations(2)

Centre Hospitalier de Cayenne

Cayenne, French Guiana

Centre Hospitalier de l'Ouest Guyanais

Saint-Laurent-du-Maroni, French Guiana

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07341997


Related Trials